USA-Trained Neurosurgeon Dr. Rao Translates Global Research into Practical Guidance, Explaining Why Personalized, Team-Based Care Is Improving Outcomes for Patients with Pituitary Tumors

A diagnosis of a pituitary adenoma can be overwhelming. Patients often worry about brain surgery, vision loss, hormonal disorders, fertility, and whether the tumor is cancerous. For many families, the first question is simple:

“Do I need brain surgery?”

According to Dr. Mohana Rao Patibandla (Dr. Rao), Founder and Chief Neurosurgeon of Dr. Rao’s Hospital – International Institute of Neurosciences, the answer is increasingly “not always.”

Modern pituitary care has evolved beyond a surgery-only approach. Today, patients benefit from individualized treatment plans developed by a multidisciplinary team that may include neurosurgeons, endocrinologists, neuro-ophthalmologists, neuroradiologists, radiation oncologists, neuro-anesthesiologists, pathologists, rehabilitation specialists, and specialized nursing teams. Depending on the type of pituitary adenoma and the patient’s clinical condition, treatment may involve endoscopic transnasal surgery, medication, stereotactic radiosurgery, hormonal replacement therapy, long-term endocrine monitoring, or careful observation.

Drawing upon advanced fellowship training in the United States in stereotactic radiosurgery, minimally invasive neurosurgery, skull base surgery, neuro-oncology, pediatric neurosurgery, and cerebrovascular neurosurgery, together with internationally published research on pituitary disorders, Dr. Rao believes that one of the greatest advances in modern neuroscience is not simply better technology—it is better clinical decision-making based on evidence and multidisciplinary collaboration.

“Every pituitary adenoma is unique. The goal is not simply to remove a tumor but to restore health, preserve vision, normalize hormonal function whenever possible, and improve quality of life. Precision medicine begins by understanding the patient, not just the MRI scan.”
— Dr. Mohana Rao Patibandla (Dr. Rao)

 

WHO Is Affected by Pituitary Adenomas?

Pituitary adenomas are among the most common benign tumors of the brain. They can affect men and women of all ages, although they are most frequently diagnosed in adults between 30 and 60 years of age.

Because the pituitary gland regulates hormones that influence nearly every organ system, these tumors can affect far more than the brain alone. Patients may experience problems involving growth, metabolism, thyroid function, adrenal function, fertility, menstrual cycles, sexual health, bone strength, and overall well-being.

Many patients first seek medical attention for symptoms that seem unrelated to the brain, often consulting endocrinologists, ophthalmologists, gynecologists, or primary care physicians before the diagnosis becomes clear.

WHAT Is a Pituitary Adenoma?

The pituitary gland is often called the “master gland” because it produces hormones that regulate many essential body functions.

A pituitary adenoma is usually a benign (non-cancerous) growth arising from this gland. 

Although these tumors rarely spread elsewhere in the body, they can significantly affect health by:

• Producing excessive hormones
• Reducing normal hormone production
• Compressing the optic nerves and causing visual loss
• Causing headaches
• Affecting fertility and reproductive health
• Influencing metabolism and body composition

Some pituitary adenomas are functioning tumors, meaning they produce excessive hormones such as growth hormone, prolactin, or ACTH. Others are non-functioning adenomas, which cause symptoms mainly because of their size and pressure on nearby structures.

Understanding the type of pituitary adenoma is one of the most important steps in selecting the appropriate treatment.

WHEN Should Patients Seek Medical Evaluation?

One of the challenges in pituitary disease is that symptoms often develop gradually.

Patients should seek specialist evaluation if they experience:

• Persistent headaches
• Progressive loss of peripheral vision
• Double vision
• Unexplained hormonal abnormalities
• Irregular menstrual cycles
• Infertility
• Erectile dysfunction
• Enlargement of the hands, feet, or facial features
• Unexplained weight gain
• Easy bruising
• Persistent fatigue
• Excessive thirst or urination
• Milk discharge unrelated to pregnancy

Early diagnosis often allows treatment before permanent visual or hormonal damage occurs.

WHERE Should Pituitary Tumors Be Treated?

Pituitary adenomas are complex disorders that frequently require expertise from multiple medical specialties.

Rather than being managed by a single physician, many patients benefit from evaluation at a comprehensive neuroscience center where specialists collaborate to develop an individualized treatment strategy.

At Dr. Rao’s Hospital – International Institute of Neurosciences, patients with pituitary disorders undergo comprehensive assessment involving neurosurgery, endocrinology, neuro-ophthalmology, advanced neuroimaging, pathology, anesthesiology, rehabilitation, and long-term follow-up.

This collaborative model reflects internationally accepted best practices for managing pituitary diseases.

WHY Has Pituitary Treatment Changed So Dramatically?

For many years, pituitary adenomas were viewed primarily as surgical diseases.

Today, scientific advances have transformed this understanding.

Depending on the diagnosis, treatment may include:

• Endoscopic transnasal pituitary surgery
• Medical therapy
• Hormonal replacement
• Stereotactic radiosurgery
• Long-term endocrine monitoring
• Observation with regular MRI scans

Modern treatment recognizes that successful care extends beyond removing a tumor.

The true objective is to preserve vision, restore hormonal balance whenever possible, reduce recurrence, improve long-term quality of life, and minimize treatment-related complications.

This evolution has been driven by decades of clinical research, technological innovation, and multidisciplinary collaboration.

HOW Does Multidisciplinary Care Improve Patient Outcomes?

A pituitary adenoma does not affect just one organ.

It influences the brain, the endocrine system, vision, metabolism, fertility, cardiovascular health, bone health, and emotional well-being.

No single specialist can address all these aspects alone.

Modern multidisciplinary care brings together experts who contribute different perspectives before treatment decisions are made.

A patient with acromegaly may require collaboration between a neurosurgeon and an endocrinologist.

A patient with visual loss may also need assessment by a neuro-ophthalmologist.

Residual or recurrent tumors may be discussed jointly with radiation oncologists to determine whether stereotactic radiosurgery is appropriate.

Similarly, long-term endocrine follow-up remains essential even after successful surgery.

This collaborative approach helps ensure that recommendations are based on the patient’s complete clinical picture rather than on a single specialty’s perspective.

From International Experience to Personalized Care

During advanced fellowship training in the United States, Dr. Rao worked alongside internationally recognized specialists managing complex pituitary disorders through multidisciplinary programs where neurosurgeons, endocrinologists, radiation oncologists, neuro-ophthalmologists, neuroradiologists, and neuropathologists jointly evaluated patients before treatment decisions were made.

Equally important, Dr. Rao contributed to internationally peer-reviewed research examining pituitary adenoma surgery, stereotactic radiosurgery for acromegaly, Cushing’s disease, Nelson’s syndrome, predictors of visual recovery after transsphenoidal surgery, and factors influencing pituitary tumor management. These collaborations with leading international institutions have helped expand scientific understanding of long-term outcomes and reinforce the importance of individualized, evidence-based care.

Returning to India, Dr. Rao’s vision was not simply to introduce advanced technology—it was to bring this philosophy of multidisciplinary, patient-centered, evidence-based pituitary care closer to patients and families.

Dr. Rao’s Philosophy

Medicine continues to evolve through scientific discovery, technological innovation, and international collaboration.

Yet one principle remains unchanged.

Patients deserve recommendations based not on routine, but on evidence.

Not on technology alone, but on thoughtful clinical judgment.

Not on what can be done, but on what should be done for that individual.

“The greatest advance in pituitary care is not that we have more treatment options. It is that we have become better at choosing the treatment that offers each patient the safest and most effective long-term outcome. Precision begins with listening, understanding, and working together as one multidisciplinary team.”
— Dr. Mohana Rao Patibandla (Dr. Rao)

 

 

Translating International Research into Better Patient Care

For decades, the treatment of pituitary adenomas focused primarily on removing the tumor. While surgery remains the cornerstone of treatment for many patients, advances in endocrinology, neuroimaging, minimally invasive skull base surgery, stereotactic radiosurgery, and long-term hormonal care have transformed the way specialists approach these complex disorders

 

 

Today, the question is no longer simply:

 

“Can the tumor be removed?”

 

Instead, physicians ask:

 

“How can we achieve the best long-term quality of life while preserving hormonal function, vision, and neurological health?”

That shift reflects one of the most important changes in modern pituitary medicine.

 

---

Research Should Improve Patients’ Lives, Not Just Medical Literature

Throughout my professional journey, I have had the privilege of contributing to internationally peer-reviewed research involving pituitary adenomas and related endocrine disorders through collaborations with leading academic institutions, including the University of Virginia and the International Gamma Knife Research Foundation. This work has examined stereotactic radiosurgery for acromegaly, Cushing’s disease, and Nelson’s syndrome, as well as surgical outcomes, visual recovery after pituitary surgery, and factors affecting pituitary tumor management.

 

While every study explored a different clinical question, they all shared the same objective:

 

To help physicians make better treatment decisions and improve the lives of patients.

 

Research should never remain confined to journals or scientific meetings.

 

Its greatest value lies in helping patients understand their condition, supporting informed decision-making, and ensuring that every treatment recommendation is based on the best available evidence.

 

---

Understanding Acromegaly: More Than Just Large Hands and Feet

 

One of the most important hormonal disorders caused by pituitary adenomas is acromegaly.

 

In this condition, a pituitary tumor produces excessive growth hormone (GH), leading to elevated levels of insulin-like growth factor-1 (IGF-1).

 

The disease develops slowly, often over many years.

 

Patients may notice:

 

• Enlargement of the hands and feet
• Changes in facial appearance
• Jaw enlargement
• Thickened skin
• Joint pain
• Excessive sweating
• Snoring or sleep apnea
• High blood pressure
• Diabetes
• Heart disease

 

Because these changes occur gradually, diagnosis is frequently delayed.

 

Many patients initially believe they are simply aging or gaining weight.

 

Early diagnosis is important because untreated acromegaly increases the risk of cardiovascular disease, metabolic complications, and reduced life expectancy.

 

International multicenter research in which Dr. Rao participated has demonstrated that stereotactic radiosurgery is an effective treatment option for carefully selected patients with persistent or recurrent acromegaly after surgery, while emphasizing the importance of long-term endocrine follow-up and individualized patient selection.

 

---

Understanding Cushing’s Disease

Another important hormone-producing pituitary tumor causes Cushing’s disease.

 

Here, the pituitary adenoma produces excessive adrenocorticotropic hormone (ACTH), stimulating the adrenal glands to produce excessive cortisol.

 

Patients may experience:

 

• Rapid weight gain
• Round “moon” face
• Purple stretch marks
• Easy bruising
• Muscle weakness
• Diabetes
• Osteoporosis
• Depression
• Anxiety
• High blood pressure
• Increased susceptibility to infections

 

Without treatment, excessive cortisol affects nearly every organ system.

 

Modern management usually begins with surgery.

 

However, some patients continue to have elevated cortisol levels after surgery or experience recurrence.

 

International collaborative research involving Dr. Rao demonstrated that stereotactic radiosurgery can provide durable hormonal control for many carefully selected patients with persistent or recurrent Cushing’s disease while highlighting the importance of long-term endocrine monitoring because remission may occur gradually and recurrence remains possible.

 

---

Nelson’s Syndrome: A Rare but Serious Condition

Some patients with severe Cushing’s disease undergo removal of both adrenal glands when other treatments are unsuccessful.

A small proportion of these patients later develop Nelson’s syndrome, in which the pituitary tumor continues to grow and produce very high ACTH levels.

 

Although uncommon, this condition requires specialized multidisciplinary management.

 

Research involving Dr. Rao and colleagues demonstrated that Gamma Knife stereotactic radiosurgery can achieve excellent tumor control in many patients with Nelson’s syndrome and may help stabilize or reduce hormone levels during long-term follow-up. These findings contribute to a growing body of evidence supporting radiosurgery as an important treatment option in carefully selected patients.

 

---

The Role of Stereotactic Radiosurgery in Pituitary Care

One of the greatest advances in pituitary treatment has been the development of stereotactic radiosurgery (SRS).

Despite its name, stereotactic radiosurgery is not traditional surgery.

 

There is:

 

• No incision
• No stitches
• No removal of bone
• No prolonged hospitalization

 

Instead, precisely focused radiation is delivered to the residual or recurrent pituitary tumor while minimizing exposure to surrounding structures such as the optic nerves, pituitary gland, and brain.

 

Radiosurgery is not a replacement for surgery.

 

Rather, it is an important component of comprehensive pituitary care.

 

Patients who may benefit include those with:

 

• Residual tumor after surgery
• Recurrent pituitary adenomas
• Persistent hormone overproduction
• Tumors unsuitable for repeat surgery
• Selected patients who are poor surgical candidates

 

International research has shown that radiosurgery provides meaningful long-term tumor control and hormonal remission for many patients when integrated into a carefully planned multidisciplinary treatment strategy.

 

---

Preserving Vision Is One of the Highest Priorities

 

Large pituitary adenomas frequently compress the optic nerves or optic chiasm.

 

Patients may notice:

 

• Blurred vision
• Reduced peripheral vision
• Difficulty reading
• Double vision
• Progressive visual loss

 

Vision often improves after appropriate treatment, particularly when compression is relieved before permanent nerve damage occurs.

 

Research involving Dr. Rao demonstrated that earlier evaluation and treatment, together with smaller tumor size at presentation, were associated with better visual recovery following transsphenoidal surgery. These findings emphasize the importance of seeking medical attention promptly when visual symptoms develop.

 

---

Every Pituitary Tumor Behaves Differently

 

One question frequently asked by both patients and surgeons is whether MRI can accurately predict how firm or soft a pituitary adenoma will be before surgery.

 

While imaging provides valuable information, internationally published research involving Dr. Rao found that tumor consistency cannot always be reliably predicted using MRI alone. This highlights why experienced surgical judgment, careful planning, and intraoperative decision-making remain essential components of successful pituitary surgery.

 

---

Evidence Supports Individualized Care

One of the strongest messages emerging from international pituitary research is that there is no single treatment suitable for every patient.

 

Some patients benefit from minimally invasive endoscopic surgery.

 

Others require medication before or after surgery.

 

Some achieve long-term disease control with stereotactic radiosurgery.

 

Others require lifelong endocrine follow-up and hormone replacement.

 

The best outcomes occur when treatment decisions are based on:

 

• Tumor type
• Hormonal profile
• MRI findings
• Visual function
• Overall health
• Patient preferences
• Scientific evidence
• Multidisciplinary discussion

 

Modern pituitary care is therefore not about choosing the most advanced technology.

It is about choosing the most appropriate treatment for each individual.

 

---

From International Collaboration to Local Patient Care

 

Returning to India after advanced fellowship training in the United States, Dr. Rao’s goal was never simply to introduce advanced neurosurgical techniques.

 

It was to bring the philosophy of evidence-based, multidisciplinary pituitary care closer to patients and families.

 

That philosophy continues to guide clinical practice at Dr. Rao’s Hospital – International Institute of Neurosciences, where neurosurgeons work alongside endocrinologists, neuro-ophthalmologists, neuroradiologists, anesthesiologists, rehabilitation specialists, and nursing teams to deliver individualized care for patients with pituitary disorders.

 

As Dr. Rao explains:

 

 

 

 

“Scientific evidence gives us knowledge. Multidisciplinary collaboration transforms that knowledge into better decisions. Ultimately, our responsibility is not simply to treat a pituitary tumor—it is to help every patient regain health, preserve function, and return to living life with confidence.”

 

The Future of Pituitary Care Is Precision, Partnership, and Personalized Medicine

 

Modern medicine is entering an era where treatment is becoming increasingly personalized. Artificial intelligence, advanced neuroimaging, molecular diagnostics, precision endocrinology, and minimally invasive surgical techniques are reshaping how pituitary tumors are diagnosed and managed.

 

Yet, despite these technological advances, one principle remains unchanged.

 

Technology should support clinical judgment—not replace it.

 

The future of pituitary care will not be determined solely by better equipment or more sophisticated software. It will be defined by how effectively multidisciplinary teams combine scientific evidence, technology, and compassionate clinical decision-making to provide individualized care for every patient.

 

At Dr. Rao’s Hospital – International Institute of Neurosciences, this philosophy guides every patient consultation, every multidisciplinary discussion, and every treatment recommendation.

 

---

Artificial Intelligence Is Supporting Better Decisions

 

Artificial intelligence (AI) is increasingly becoming an important tool in neuroscience.

 

AI-assisted technologies may help physicians:

 

• Analyze MRI scans with greater precision
• Detect subtle changes in pituitary tumors during follow-up
• Assist in treatment planning
• Predict surgical risks
• Improve radiation treatment planning
• Support endocrine data analysis
• Enhance long-term patient monitoring

 

However, AI does not replace experience.

 

It cannot understand a patient’s fears.

 

It cannot appreciate individual goals.

 

It cannot weigh family circumstances, professional responsibilities, or quality-of-life considerations.

 

Only experienced physicians working together with patients can make those decisions.

 

The future therefore belongs to AI-assisted medicine—not AI-directed medicine.

 

---

Precision Medicine Begins Before Treatment

 

Precision medicine is often misunderstood as simply using advanced technology.

 

In reality, precision begins much earlier.

 

It begins by asking the right questions.

 

• What type of pituitary adenoma is this?
• Is it producing excess hormones?
• Is vision threatened?
• What are the patient’s symptoms?
• What are the patient’s priorities?
• What treatment offers the greatest long-term benefit?

 

Sometimes the answer is surgery.

 

Sometimes medication.

 

Sometimes stereotactic radiosurgery.

 

Sometimes careful observation.

 

Choosing correctly is far more important than choosing quickly.

 

---

The Importance of Lifelong Partnership

 

Treatment of a pituitary adenoma does not necessarily end after surgery or radiosurgery.

 

Many patients require:

 

• Periodic MRI scans
• Hormonal assessment
• Vision testing
• Medication adjustment
• Long-term endocrinology follow-up
• Rehabilitation when appropriate

 

Successful pituitary care is therefore a long-term partnership between patients and their healthcare team.

The objective extends far beyond tumor control.

 

The goal is restoring health, preserving neurological function, maintaining hormonal balance whenever possible, protecting vision, and helping patients return to productive, fulfilling lives.

 

---

What Patients Should Remember

 

Receiving a diagnosis of a pituitary adenoma can be frightening.

 

Fortunately, today’s treatment options are better than ever before.

 

Patients should remember:

 

• Most pituitary adenomas are benign.
• Many pituitary tumors are highly treatable.
• Early diagnosis improves outcomes.
• Not every pituitary adenoma requires immediate surgery.
• Modern treatment often involves multiple specialists working together.
• Long-term follow-up is an important part of successful care.
• Every treatment plan should be individualized.

 

Perhaps the most important message is this:

 

Every patient’s journey is different.

 

There is no single treatment suitable for everyone.

 

The best treatment is the one that fits the individual patient.

 

---

A Message from Dr. Rao

Reflecting on years of clinical practice, international fellowship training, research, and patient care, Dr. Rao believes that the greatest lesson medicine has taught him is remarkably simple.

 

“Patients do not come to us because they need surgery. They come because they need answers, guidance, and hope. Our responsibility is to recommend the treatment that offers the greatest opportunity for long-term health—not simply the treatment we are most comfortable performing. When science, multidisciplinary collaboration, and compassion work together, patients receive the care they truly deserve.”

 

---

When Should You Seek Medical Attention?

Consult an experienced neurosurgeon and endocrinologist if you experience:

 

• Persistent headaches
• Progressive visual loss
• Double vision
• Menstrual irregularities
• Infertility
• Erectile dysfunction
• Excessive growth of hands or feet
• Unexplained weight gain
• Features suggestive of Cushing’s syndrome
• Hormonal abnormalities
• Pituitary tumor identified on MRI

 

Early evaluation allows timely diagnosis and access to the full range of modern treatment options before complications become permanent.

 

---

About Dr. Rao

Dr. Mohana Rao Patibandla (Dr. Rao), M.Ch (NIMS), FESBSS (KIMS), FAANS (USA), FMINS (OSU, USA), FEVNS (UVA, USA), FPNS (UCD, USA), FNOSRS (UVA, USA), is a USA-trained neurosurgeon and the Founder and Chief Neurosurgeon of Dr. Rao’s Hospital – International Institute of Neurosciences, Guntur, Andhra Pradesh, India.

 

Following neurosurgical training in India, he completed advanced fellowship training in the United States in minimally invasive neurosurgery, skull base surgery, stereotactic radiosurgery, pediatric neurosurgery, neuro-oncology, and cerebrovascular/endovascular neurosurgery.

 

His clinical practice focuses on evidence-based, patient-centered management of brain tumors, pituitary disorders, cerebrovascular diseases, skull base lesions, spine disorders, pediatric neurosurgery, functional neurosurgery, and minimally invasive brain and spine surgery.

 

Dr. Rao has contributed to internationally peer-reviewed research in pituitary adenomas, acromegaly, Cushing’s disease, Nelson’s syndrome, stereotactic radiosurgery, brain tumors, cerebrovascular diseases, skull base surgery, and complex neurosurgical disorders through collaborations with leading international academic institutions.

 

---

About Dr. Rao’s Hospital – International Institute of Neurosciences

 

Dr. Rao’s Hospital – International Institute of Neurosciences is one of India’s dedicated neuroscience centers providing comprehensive care for disorders of the brain, spine, nerves, and cerebrovascular system.

 

The hospital integrates:

 

• Advanced neuroimaging
• Endoscopic skull base surgery
• Minimally invasive neurosurgery
• Stereotactic radiosurgery
• Endovascular neurosurgery
• Neurocritical care
• Neurorehabilitation
• Comprehensive endocrinology collaboration
• Multidisciplinary treatment planning

 

This integrated approach allows individualized care for patients with pituitary adenomas and other complex neurological disorders.

 

---

Contact Information

 

Dr. Rao’s Hospital – International Institute of Neurosciences

12-19-67, Old Bank Road, Kothapet,
Beside AK Biryani Point,
Guntur, Andhra Pradesh – 522001, India

 

Phone: +91 9010056444

Email: info@drraoshospitals.com
drpatibandla@gmail.com

Website: https://drraoshospitals.com

 

---

References

 

1. Ding D, Mehta GU, Patibandla MR, et al. Stereotactic Radiosurgery for Acromegaly: An International Multicenter Retrospective Cohort Study. Neurosurgery. 2019.
2. Patibandla MR, Xu Z, Sheehan JP. Factors Affecting Early Versus Late Remission in Acromegaly Following Stereotactic Radiosurgery. Journal of Neuro-Oncology. 2018.
3. Mehta GU, Ding D, Patibandla MR, et al. Stereotactic Radiosurgery for Cushing Disease: Results of an International, Multicenter Study. Journal of Clinical Endocrinology & Metabolism. 2017.
4. Caruso JP, Patibandla MR, Xu Z, Vance ML, Sheehan JP. A Long-Term Study of the Treatment of Nelson’s Syndrome With Gamma Knife Radiosurgery. Neurosurgery. 2018.
5. Thotakura AK, Patibandla MR, Panigrahi MK, Mahadevan A. Is It Really Possible to Predict the Consistency of a Pituitary Adenoma Preoperatively? Neurochirurgie. 2017.
6. Thotakura AK, Patibandla MR, Panigrahi MK, Addagada GC. Predictors of Visual Outcome With Transsphenoidal Excision of Pituitary Adenomas Having Suprasellar Extension. Asian Journal of Neurosurgery. 2017.  
7.  

A nonfunctioning pituitary adenoma (NFA) is a benign growth in the pituitary gland that does not produce any excessive hormone into the blood and is not cancerous. Non-functioning pituitary adenomas account for 15% of all pituitary adenomas, with approximately 70-90 cases per one million people. If you are looking for the pituitary adenoma management don’t look any further other than Dr. Rao’s hospital, Dr. Mohana Rao Patibandla is trained in both minimally invasive surgery and stereotactic radiosurgery to treat your tumor.

Symptoms of a Nonfunctioning Pituitary Adenoma

These tumors do not result in symptoms based on excess production of hormones. Because of this, doctors can’t diagnose it until the tumor affects other structures, resulting in visual loss or headaches. In some patients, the tumor may compress the pituitary stalk and pituitary gland and cause a loss of the pituitary’s usual role in controlling the reproductive, thyroid, and adrenal gland function.

The earliest symptom of hormone deficiency is typically a loss of sexual function in men (from low testosterone) and loss of menstrual periods in women. People may also experience fatigue from low thyroid or cortisol levels. Some tumors are discovered incidentally when you’re being assessed for other reasons, such as an MRI scan performed after a car accident.

Symptoms related to the tumor:

• Headache
• Visual decline: blurred vision or difficulty with peripheral vision

Symptoms related to hormonal deficiency include:

• Growth hormone deficiency
• Growth failure in children
• Hypogonadism (low reproductive hormones)
• Delayed puberty in children
• Reduced or loss of sex drive
• Menstrual irregularities/loss of menstrual cycle
• Infertility
• Hypercortisolism (low cortisol)
• Weakness
• Fatigue
• Weight loss
• Hypothyroidism (low thyroid)
• Sensitivity to cold
• Fatigue
• Weight gain
• Personality changes
• Diabetes insipidus (low antidiuretic hormone)
• Frequent urination
• Excessive thirst
• Progressive loss of vision
• Hormone deficiencies

Diagnosis & Treatment at Dr. Rao’s Hospital

An endocrinologist determines which blood tests are necessary to investigate whether there are pituitary hormone deficiencies.

Although a pituitary adenoma can be seen on a regular MRI, you may require more detailed imaging of the pituitary to determine the anatomy of the tumor and its relation to the optic nerves and the pituitary gland.

Patients with visual symptoms are often referred for formal visual testing by a neuro-ophthalmologist. If you lose your vision, you’ll need immediate treatment.

Medications

There are no consistently effective medical treatments for this type of tumor. There are isolated reports of treatment with a dopamine agonist drug that showed some decrease in the tumor size. However, this occurred in a small number of patients.

If pituitary deficiencies are present before the surgery, hormone replacements will be prescribed to compensate for the loss of hormone production. This type of medication will not shrink or remove the tumor.

Surgery

Although small tumors can often be followed without surgery, large nonfunctioning adenomas require surgery to remove as much of the tumor as possible.

Effective surgical treatment can improve vision and prevent additional vision loss. You might require hormone replacements even if you did not require these before. At follow-up, you’ll undergo a complete hormonal evaluation to determine which hormone(s) need to be replaced.

Stereotactic Radiosurgery

The size and location of your tumor determine whether or not you need radiation therapy.

Since many NFAs are large, they may have grown large enough to surround other structures, such as the carotid artery or the optic nerves. Surgery alone can’t remove the entire tumor in these cases, but radiation therapy can shrink the remaining tumor.

Monitoring After Treatment

All pituitary adenomas, including a nonfunctioning adenoma, may recur at any time. You must get an MRI scan yearly for at least five years after surgery. You can have your MRI every two years if your tumor doesn’t recur. For the same, You need to consult your neurosurgeon and your endocrinologist.

While a nonfunctioning pituitary adenoma is a benign tumor, it requires treatment, regular monitoring, and follow-up. You can live everyday life with successful surgery and appropriate hormone replacement.

If you are looking for the pituitary adenoma management don’t look any further other than Dr. Rao’s hospital, Dr. Mohana Rao Patibandla is trained in both minimally invasive surgery and stereotactic radiosurgery to treat your tumor. Call us @9010056444 or 9010057444 for further queries.